Widespread eczema from triflusal confirmed by patch testing.
Sánchez-Machín
I
I
Servicio de Alergia, Hospital Universitario Nuestra Senora de Candelaria, 38010 Santa Cruz de Tenerife, Canary Islands, Spain.
García Robaina
J C
JC
Torre Morin
F
F
D003924:Diabetes Mellitus, Type 2; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D004485:Eczema / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D006801:Humans; D006937:Hypercholesterolemia; D006973:Hypertension; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D010328:Patch Tests; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D012459:Salicylates / Q000009:adverse effects*
D010975:Platelet Aggregation Inhibitors; D012459:Salicylates; C016167:triflusal